Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
56 /100
HIGH RISK
Score updated Aug 28, 2026

BDSX — Biodesix, Inc. Dilution Risk Tracker

Track BDSX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BDSX — Get alerts when the score changes →

As of August 28, 2026, Biodesix, Inc. (BDSX) has a DilutionWatch DilutionScore of 56/100, rated HIGH dilution risk. Biodesix, Inc. has a market capitalization of $169.01M, 10.55M shares outstanding, 41 institutional holders tracked. Stored dilution-related fields include 103.3K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
52
💰 Cash Runway
65
📊 Float Risk
50
⚠️ Warrant Exposure
15
🔄 Convertible Debt
35

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 12%
💰 Capital Raise model 15%
• Under 12 months cash (9mo)
🔁 Convertible Conversion model 15%
• Convertible debt present: 7.7% potential dilution
🔔 Track BDSX — Get forecast alerts →

Market Data

Market Cap$169.01M
Shares Outstanding10.55M
Float4.99M
Cash$30.00M
Debt$50.00M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 191.7% shares (2026Q1 vs prior)
41 institutional holders · 3.97M shares
#1 AIGH Capital Management LLC 758.3K shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 510.3K shares
#3 Telemark Asset Management, LLC 489.8K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest157.2K
Days to Cover2.7
% of Float3.1%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31
xbrl XBRL CONVERTIBLE 2024-12-31
Form 4 INSIDER TRANSACTION 2026-08-12
Form 4 INSIDER TRANSACTION 2026-08-11
Form 4 INSIDER TRANSACTION 2026-08-10
Full SEC filing analysis available with free account

Recent News

No recent news

Factual BDSX Dilution Snapshot

Biodesix, Inc. (BDSX) has a DilutionScore of 56/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track BDSX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BDSX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for BDSX
BDSX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.